Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 [The role of progestins].

Literature DB >> 2686564

[The role of progestins].

H I Wyss.

Abstract

Mesh：

Substances：
Progestins

Year: 1989 PMID： 2686564 DOI： 10.1007/bf00935858

Source DB: PubMed Journal: Arch Gynecol Obstet ISSN： 0932-0067 Impact factor: 2.344

Keyword Cloud
References

× No keyword cloud information.

37 in total

1. Estrogens and endometrial cancer in a retirement community.

Authors: T M Mack; M C Pike; B E Henderson; R I Pfeffer; V R Gerkins; M Arthur; S E Brown
Journal: N Engl J Med Date: 1976-06-03 Impact factor: 91.245

2. Conversion of oral progesterone into deoxycorticosterone during postmenopausal replacement therapy.

Authors: U B Ottosson; K Carlström; J E Damber; B von Schoultz
Journal: Acta Obstet Gynecol Scand Date: 1984 Impact factor: 3.636

3. Serum levels of progesterone and some of its metabolites including deoxycorticosterone after oral and parenteral administration.

Authors: U B Ottoson; K Carlstrom; J E Damber; B von Schoultz
Journal: Br J Obstet Gynaecol Date: 1984-11

4. Noncontraceptive estrogen use and the occurrence of ovarian cancer.

Authors: C La Vecchia; A Liberati; S Franceschi
Journal: J Natl Cancer Inst Date: 1982-12 Impact factor: 13.506

5. Estrogen plus progestin in postmenopausal women.

Authors: P C MacDonald
Journal: N Engl J Med Date: 1981-12-31 Impact factor: 91.245

6. Intracellular estradiol, estrone and estrogen receptor levels in endometria from postmenopausal women receiving estrogens and progestins.

Authors: R J King; G Dyer; W P Collins; M I Whitehead
Journal: J Steroid Biochem Date: 1980-04 Impact factor: 4.292

[The role of progestins].

1. Estrogens and endometrial cancer in a retirement community.

2. Conversion of oral progesterone into deoxycorticosterone during postmenopausal replacement therapy.

3. Serum levels of progesterone and some of its metabolites including deoxycorticosterone after oral and parenteral administration.

4. Noncontraceptive estrogen use and the occurrence of ovarian cancer.

5. Estrogen plus progestin in postmenopausal women.

6. Intracellular estradiol, estrone and estrogen receptor levels in endometria from postmenopausal women receiving estrogens and progestins.

7. Oestradiol: the predominant intranuclear oestrogen in the endometrium of oestrogen-treated postmenopausal women.

8. Recent and past use of conjugated estrogens in relation to adenocarcinoma of the endometrium.

9. Exogenous estrogens and endometrial cancer: a case-control study and assessment of potential biases.

10. Endometrial histology and biochemistry in climacteric women during oestrogen and oestrogen/progestogen therapy.